FDA proposes curbs on mass copycats of Novo, Lilly's weight-loss drugs The Food and Drug Administration on April 30 proposed excluding Novo Nordisk and Eli Lilly's weight-loss drugs from a key compounding list, potentially limiting large-scale production by outsourcing facilities
Confirm that a provider licensed in your state signs off on your prescription
GLP-1 signaling may protect brain cells and reduce neuroinflammation, potentially benefiting cognition and mood in some individuals
Our medical team will evaluate your medical history, lifestyle, weight loss goals, and recommend personalized solutions, including safe and effective weight loss injections, to determine if this program is right for you
Without a valid prescription, you cant purchase/use compounded semaglutide
Our comprehensive range of IV therapies is designed with you in mind, helping you achieve your goals while looking and feeling your healthiest